Regulation of the immune response to antigens on the malignant cell surface.
D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics / Q000276:immunology*; D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology*; D000961:Antilymphocyte Serum / Q000494:pharmacology / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000276:immunology*; D002472:Cell Transformation, Viral; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007156:Immunologic Memory; D008213:Lymphocyte Activation / Q000528:radiation effects; D008222:Lymphokines / Q000378:metabolism; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D009381:Neoplasms, Radiation-Induced / Q000276:immunology; D010641:Phenotype; D011120:Polyomavirus / Q000276:immunology; D013491:Suppressor Factors, Immunologic; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology / Q000528:radiation effects; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000961:Antilymphocyte Serum; D000949:Histocompatibility Antigens Class II; D008222:Lymphokines; D013491:Suppressor Factors, Immunologic